Thoughtful philanthropy, rooted in partnership, purpose, and impact.
The Banga Family Trust is guided by a simple belief:
philanthropy should deliver tangible, lasting impact for people and communities.
About the Trust
High-Impact Philanthropy
My husband, Vindi, and I established the Trust in 2018. We both feel deeply grateful for the opportunities and upbringing we’ve had, and we consider it a privilege to give back by supporting causes that matter to us.
The Trust’s initial focus was on supporting cancer research as both my mother and I were diagnosed with breast cancer. Since then, it has grown to encompass initiatives which mirror mine and Vindi’s shared values and passion points - the arts, progressive thinking, and projects which are rooted in a deep commitment to social good.
All our beneficiary partnerships have a strong foundation built from trust, insight, and shared ambition. In many cases, this means we contribute not only financial support, but also invest our time, strategic thinking, and governance expertise.
Our work is guided by a clear focus on delivering results and positive changes - today, tomorrow, and for generations to come. We seek depth over breadth, and partnerships that endure.
Our long-term vision is shared by our sons, Tavraj and Udaibir, who are committed to continuing this work into the future.
The Trust focuses primarily on the UK in recognition of the fact that it was only when I moved to this country that I found my voice and felt able to share my thinking and opinions freely and without judgement.
This website offers an overview of the Trust’s activities to date and highlights the areas and initiatives we are keen to explore going forward. If you’re looking for support, you can find an application form in the Apply section.
We’d like to thank all our partners in helping us collate their case studies which I hope you’ll enjoy reading so you can find out more about the amazing work they all do.
— Kamini Banga
Our Areas of Focus
The Trust champions cancer research and patient support through long-term partnerships with leading research and care institutions, funding innovation, strengthening organisations, and improving outcomes for patients and families.
Science with Purpose, Care with Humanity
The Trust supports arts organisations that inspire inclusion, amplify new voices, and connect communities, using culture to educate, challenge, and build meaningful dialogue across generations and borders.
Arts as a Driver of Social Change
The Trust advances open, compassionate dialogue, supporting spaces for evidence-based debate and free expression that bridge divides and enable thoughtful engagement with complex global issues.
Supporting Progressive Thought Leadership
Our Trustees
-
![]()
Professor Sir Roy Anderson
Sir Roy Anderson FRS, FMedSci was Rector of Imperial College London from 1 July 2008 to 31 December 2009, following a 40-year association with the College. He continues to be Professor of Infectious Disease Epidemiology in the Division of Epidemiology, Public Health and Primary Care.
Sir Roy was elected Fellow of the Royal Society in 1986, a Founding Fellow of the Academy of Medical Sciences in 1998, a Foreign Associate Member of the Institute of Medicine at the US National Academy of Sciences in 1999 and he was knighted in the 2006 Queen's Birthday Honours.
-
![]()
Lord Jitesh Gadhia
Lord Gadhia is a British investment banker and businessman and has been a Member of the House of Lords since September 2016. He was previously Senior Managing Director at Blackstone based in London and has over 25 years' financial services experience, having also held senior positions at Barclays Capital, ABN AMRO and Baring Brothers.
He graduated from Cambridge University with a degree in economics and attended the London Business School as a Sloan Fellow. He has also served as a Trustee of Guy’s and St Thomas’ Charity and of Nesta.
-
![]()
Sir Leszek Borysiewicz
Professor Sir Leszek Borysiewicz is trained as a clinician and immunologist. He has held numerous prestigious positions, including Vice-Chancellor of the University of Cambridge from 2010 to 2017, Chief Executive Officer of the Medical Research Council from 2007 to 2010, Deputy Rector of Imperial College London from 2004 to 2007, and Chair of Cancer Research UK from 2016 to 2023.
He is a Fellow of the Royal Society and a founding Fellow of the Academy of Medical Sciences. In 2001, he was knighted in recognition for his significant contributions to medical research and education. In 2025, he was awarded the Knight Grand Cross of the Order of the British Empire (GBE) for services to cancer research, clinical research, medicine and charities.
